Literature DB >> 4600820

Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study.

K Andrassy, H Malluche, H Bornefeld, M Comberg, E Ritz, H Jesdinsky, K Möhring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4600820     DOI: 10.1007/bf01468835

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  4 in total

1.  THROMBIN GENERATION IN NORMAL SUBJECTS AND CARDIAC PATIENTS.

Authors:  K N VONKAULLA; E VONKAULLA
Journal:  Circ Res       Date:  1964-05       Impact factor: 17.367

2.  [Laboratory diagnosis of hemophilias].

Authors:  H Egli
Journal:  Dtsch Med J       Date:  1968-07-20

3.  [Agglutination and adhesiveness of thrombocytes after physical effort].

Authors:  K Breddin; W Hach
Journal:  Thromb Diath Haemorrh       Date:  1966-01-31

4.  The effect of acetylsalicyclic acid on platelet function.

Authors:  G Evans; M A Packham; E E Nishizawa; J F Mustard; E A Murphy
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

  4 in total
  18 in total

Review 1.  Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.

Authors:  M Verstraete
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 2.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

Review 3.  Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.

Authors:  Nicola C Tanner; Anthony Da Silva
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

4.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

5.  Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

Authors:  A Ghorbani; M Aalamshah; H Shahbazian; A Ehsanpour; A Aref
Journal:  Indian J Nephrol       Date:  2009-04

6.  [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1977-01-15

7.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

Review 8.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

9.  A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation.

Authors:  Christoph B Olivier; Vandana Sundaram; Glenn M Chertow; Sumana Shashidhar; Lori K McDonnell; Victoria Y Ding; Manisha Desai; Kenneth W Mahaffey; Matthew Mell
Journal:  J Vasc Access       Date:  2019-11-27       Impact factor: 2.283

10.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.